Exsilio Therapeutics

CEO - Tal Zaks

Country: USA | Funding: $82M (+)
Founded: 2022

Website: https://exsiliotx.com

Exsilio develops genomic therapeutics that introduce therapeutic genes into safe shelters within the DNA.

Competitors

Moderna Therapeutics

Arrowhead Pharmaceuticals

BioNTech

Promote Startup